Overview
Edinburgh Worldwide aims for capital growth from a global portfolio of initially immature entrepreneurial companies, typically with a market capitalisation of less than $5bn at time of initial investment, which are believed to offer long-term growth potential.
While the policy is global investment, the approach adopted is to construct a portfolio through the identification of individual companies which offer long-term growth potential.
Performance & Portfolio
Periodic Performance
All figures to 30/11/2024 1 Year
3 Years
5 Years
10 Years
Share Price 32.9% -40.8% -8.4% 132.0% NAV 17.0% -39.4% -3.8% 114.5% Index* 24.0% 17.4% 53.8% 165.4% Performance figures appear in GBP. The value of your investment may go down as well as up, and you may not get back the amount you invested.
NAV is calculated with borrowings deducted at fair value for 1, 3 and 5 years and par value for 10 years.
*Changed from MSCI AC World to S&P Global Small Cap on 01/02/2014. Data chain-linked from this date to form a single index.
Performance source: Morningstar and relevant underlying index provider(s), total return.
Please bear in mind that past performance is not a guide to future performance.
Discrete Performance
Annual Performance to 30 September each year 30/09/2019
30/09/202030/09/2020
30/09/202130/09/2021
30/09/202230/09/2022
30/09/202330/09/2023
30/09/2024Share Price 58.7% 5.3% -43.3% -20.1% 11.1% NAV 58.3% 12.4% -37.7% -17.0% 2.5% Index* -1.4% 33.6% -9.1% 5.1% 13.1% Performance figures appear in GBP. The value of your investment may go down as well as up, and you may not get back the amount you invested.
NAV is calculated with borrowings deducted at fair value for 1, 3 and 5 years and par value for 10 years.
*Changed from MSCI AC World to S&P Global Small Cap on 01/02/2014. Data chain-linked from this date to form a single index.
Performance source: Morningstar and relevant underlying index provider(s), total return.
Please bear in mind that past performance is not a guide to future performance.Performance - 30/11/2024Performance figures appear in GBP. The value of your investment may go down as well as up, and you may not get back the amount you invested.
Comparative Index is limited to a 5 year period from the current date.
Comparative Index changed from MSCI All Countries World Index on 01/02/2014 to S&P Global Small Cap Index. In the above graph the indices have been chain-linked to form a single index.
The graph has been rebased to 100.
Please bear in mind that past performance is not a guide to future performance.Holdings - 30/11/2024
Fund % 1 Space Exploration Technologies 8.4% 2 PsiQuantum 5.6% 3 Alnylam Pharmaceuticals 5.1% 4 Zillow 4.3% 5 Axon Enterprise 4.0% 6 AeroVironment 3.5% 7 Oxford Nanopore Tech 3.2% 8 American Superconductor Corp 2.8% 9 Sweetgreen 2.3% 10 Upwork 2.0% Total 41.2% Active Share - 30/11/2024Relative to S&P Global Small Cap. Source: Baillie Gifford & Co, S&P.
Geographical analysis of total assets - 30/11/2024Fund %
- 1 North America 70.10
- 2 UK 9.97
- 3 Europe 4.31
- Israel 2.79
- Others 1.52
- 4 Asia 5.23
- China 3.08
- Japan 2.14
- 5 Australasia 1.69
- 6 Net Liquid Assets 7.33
- 7 Others 0.17
- 8 Others 1.20
- Total 100.00
As the Fund invests in overseas securities, changes in the rates of exchange may also cause the value of your investment (and any income it may pay) to go down or up.
The information contained on this page is intended as a guide only and should not be relied upon when making investment decisions. All holdings information is unaudited. Source Baillie Gifford & Co.
Please note that totals may not add due to rounding.Insights
View all Insights.Meet the Managers
Douglas Brodie - Co-manager
Douglas is head of the Global Discovery Team and has led the strategy since its inception. He is also a co-manager of the Edinburgh Worldwide Investment Trust. He joined Baillie Gifford in 2001 and became a partner in 2015. He graduated with a BSc in Molecular Biology and Biochemistry from the University of Durham in 1997 and attained a DPhil in Molecular Immunology from the University of Oxford in 2001.
Svetlana Viteva - Co-manager
Svetlana is an investment manager in the Global Discovery Team. She is a member of the Discovery PCG and a co-manager of the Edinburgh Worldwide Investment Trust. She joined Baillie Gifford in 2012. She graduated with a BA in Economics and Business Administration from the American University in Bulgaria in 2008, an MSc in Investment Analysis in 2009 and a PhD in Accounting and Finance in 2012, both from the University of Stirling. She is a CFA Charterholder.
Luke Ward - Co-manager
Luke is an investment manager in the Private Companies Team and a co-manager for the Edinburgh Worldwide Investment Trust. He joined Baillie Gifford in 2012 and, prior to joining the Private Companies Team in 2024, was an investment manager in the Discovery Team. Luke graduated from the University of Edinburgh in 2012 with an MEng (Hons) in Mechanical Engineering.
How to Buy
Further information on the funds can be found in the relevant Key Investor Information and Prospectus Documents, which are available in English and will be sent to you free of charge on request.
You can invest in our funds via a number of fund platforms. Information on the range of funds available through platforms can be obtained from platforms@bailliegifford.com
Documents
You can access any literature about the Fund here, either by downloading or requesting a copy by post (where available).
To download any document you will need Adobe Reader. Please note that we can now provide you with Braille and audio transcriptions of our literature on request. It may take up to 10 days for the transcription to be completed dependent on the size of the document.
Annual reports
Corporate governance
Factsheets
Fund ratings reports
Interim reports
Investment intelligence
Investor disclosure document
Other fund literature
Philosophy and process documents
Portfolio valuation
Portfolio voting disclosure
RNS announcements
Sustainability-related disclosures and climate reports
PRIIPs key information document
Risks
Any investment in an investment trust involves risk. You should be aware of the following risks when considering investing.
Past performancePast performance is not a guide to future performance.
The value of your investment
The investment trusts managed by Baillie Gifford & Co Limited are listed UK companies and are not authorised or regulated by the Financial Conduct Authority. The value of their shares, and any income from them, can fall as well as rise and investors may not get back the amount invested.
Overseas investment
The Trust invests in overseas securities. Changes in the rates of exchange may also cause the value of your investment (and any income it may pay) to go down or up.
Gearing
The Trust can borrow money to make further investments (sometimes known as “gearing” or “leverage”). The risk is that when this money is repaid by the Trust, the value of the investments may not be enough to cover the borrowing and interest costs, and the Trust will make a loss. If the Trust's investments fall in value, any invested borrowings will increase the amount of this loss.
Share buy-backs
The Trust can buy back its own shares. The risks from borrowing, referred to above, are increased when a trust buys back its own shares.
Liquidity
Market values for securities which have become difficult to trade may not be readily available and there can be no assurance that any value assigned to such securities will accurately reflect the price the Trust might receive upon their sale.
Derivatives
The Trust can make use of derivatives to obtain, increase or reduce exposure to assets and may result in the Trust being leveraged. Derivatives are most often used to compensate for possible unfavourable currency and market movements. This may result in greater movements (down or up) in the net asset value of the Trust. It is not our intention that the use of derivatives will significantly alter the overall risk profile of the Trust. A further risk exists in respect of the counterparty with whom the derivative transaction is made. Due care and diligence is exercised in the selection of counterparties, however, the possibility of the counterparty failing to pay sums due to the Trust still remains.
Smaller Immature Companies
Investment in smaller, immature companies is generally considered higher risk as changes in their share prices may be greater and the shares may be harder to sell. Smaller, immature companies may do less well in periods of unfavourable economic conditions.
Private Companies
Unlisted investments such as private companies, in which the Trust has a significant investment, can increase risk. These assets may be more difficult to sell, so changes in their prices may be greater.
Charges to capital
The Trust charges 75% of the investment management fee and borrowing costs to capital which reduces the capital value. Also, where income is low, the remaining expenses may be greater than the total income received, meaning the Trust may not pay a dividend and the capital value would be further reduced.
Income is less important
The aim of the Trust is to achieve capital growth. You should not expect a significant, or steady, annual income from the Trust.
Tax Rates
You should note that tax rates and reliefs may change at any time and their value depends on your circumstances.
Regulation
The Trust is listed on the London Stock Exchange and is not authorised or regulated by the Financial Conduct Authority.
Information subject to change
The information and opinions expressed within this website are subject to change without notice.
Not Investment Advice
This information has been issued and approved by Baillie Gifford & Co Limited and does not in any way constitute investment advice.
Suitability for retail distribution
Please note that the Company currently conducts its affairs, and intends to continue to conduct its affairs, so that the Company’s ordinary shares can be recommended by Independent Financial Advisers to ordinary retail investors in accordance with the FCA’s rules in relation to non-mainstream pooled investment products (NMPI). The Company’s ordinary shares are excluded from the FCA’s restrictions which apply to non-mainstream pooled investment products because they are shares in an investment trust.
Disclaimers
MSCI DISCLAIMER
Source: MSCI. The MSCI information may only be used for your internal use, may not be reproduced or disseminated in any form and may not be used as a basis for or a component of any financial instruments or products or indices. None of the MSCI information is intended to constitute investment advice or a recommendation to make (or refrain from making) any kind of investment decision and may not be relied on as such. Historical data and analysis should not be taken as an indication or guarantee of any future performance analysis, forecast or prediction. The MSCI information is provided on an “as is” basis and the user of this information assumes the entire risk of any use made of this information. MSCI, each of its affiliates and each other person involved in or related to compiling, computing or creating any MSCI information (collectively, the “MSCI Parties”) expressly disclaims all warranties (including, without limitation, any warranties of originality, accuracy, completeness, timeliness, non-infringement, merchantability and fitness for a particular purpose) with respect to this information. Without limiting any of the foregoing, in no event shall any MSCI Party have any liability for any direct, indirect, special, incidental, punitive, consequential (including, without limitation, lost profits) or any other damages. (www.msci.com)
S&P DOW JONES DISCLAIMER
The S&P 500 and S&P Global SmallCap (index) is a product of S&P Dow Jones Indices LLC or its affiliates (“SPDJI”) and has been licensed for use by Baillie Gifford &Co. Standard & Poor’s® and S&P® are registered trademarks of Standard & Poor’s Financial Services LLC (“S&P”); Dow Jones® is a registered trademark of Dow Jones Trademark Holdings LLC (“Dow Jones”); and these trademarks have been licensed for use by SPDJI and sublicensed for certain purposes by Baillie Gifford & Co. Baillie Gifford & Co product(s) is not sponsored, endorsed, sold or promoted by SPDJI, Dow Jones, S&P, their respective affiliates, and none of such parties make any representation regarding the advisability of investing in such product(s) nor do they have any liability for any errors, omissions, or interruptions of The S&P 500 and S&P Global SmallCap (index).
